ESGO/ESTRO/ESP Guidelines for the management of patients with cervical cancer - Update 2023∗

David Cibula*, Maria Rosaria Raspollini, François Planchamp, Carlos Centeno, Cyrus Chargari, Ana Felix, Daniela Fischerová, Daniela Jahnn-Kuch, Florence Joly, Christhardt Kohler, Sigurd Lax, Domenica Lorusso, Umesh Mahantshetty, Patrice Mathevet, Raj Naik, Remi A. Nout, Ana Oaknin, Fedro Peccatori, Jan Persson, Denis QuerleuSandra Rubio Bernabé, Maximilian P. Schmid, Artem Stepanyan, Valentyn Svintsitskyi, Karl Tamussino, Ignacio Zapardiel, Jacob Lindegaard

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

59 Citations (Scopus)
39 Downloads (Pure)

Abstract

In 2018, the European Society of Gynecological Oncology (ESGO) jointly with the European Society for Radiotherapy and Oncology (ESTRO) and the European Society of Pathology (ESP) published evidence-based guidelines for the management of patients with cervical cancer. Given the large body of new evidence addressing the management of cervical cancer, the three sister societies jointly decided to update these evidence-based guidelines. The update includes new topics to provide comprehensive guidelines on all relevant issues of diagnosis and treatment in cervical cancer. To serve on the expert panel (27 experts across Europe) ESGO/ESTRO/ESP nominated practicing clinicians who are involved in managing patients with cervical cancer and have demonstrated leadership through their expertise in clinical care and research, national and international engagement, profile, and dedication to the topics addressed. To ensure the statements were evidence based, new data identified from a systematic search was reviewed and critically appraised. In the absence of any clear scientific evidence, judgment was based on the professional experience and consensus of the international development group. Before publication, the guidelines were reviewed by 155 independent international practitioners in cancer care delivery and patient representatives. These updated guidelines are comprehensive and cover staging, management, follow-up, long-term survivorship, quality of life and palliative care. Management includes fertility sparing treatment, early and locally advanced cervical cancer, invasive cervical cancer diagnosed on a simple hysterectomy specimen, cervical cancer in pregnancy, rare tumors, recurrent and metastatic diseases. The management algorithms and the principles of radiotherapy and pathological evaluation are also defined.

Original languageEnglish
Pages (from-to)649-666
Number of pages18
JournalInternational Journal of Gynecological Cancer
Volume33
Issue number5
Early online date1 May 2023
DOIs
Publication statusPublished - 2023

Bibliographical note

Funding:
All costs relating to the development process were covered from ESGO
and ESP funds. There was no external funding of the development process or
manuscript production.

Publisher Copyright:
© 2023 BMJ Publishing Group. All rights reserved.

Fingerprint

Dive into the research topics of 'ESGO/ESTRO/ESP Guidelines for the management of patients with cervical cancer - Update 2023∗'. Together they form a unique fingerprint.

Cite this